verapamil has been researched along with Gingival Hyperplasia in 9 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Gingival Hyperplasia: Non-inflammatory enlargement of the gingivae produced by factors other than local irritation. It is characteristically due to an increase in the number of cells. (From Jablonski's Dictionary of Dentistry, 1992, p400)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 8 (88.89) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steele, RM | 1 |
| Schuna, AA | 1 |
| Schreiber, RT | 1 |
| Cebeci, I | 1 |
| Kantarci, A | 1 |
| Firatli, E | 1 |
| Carin, M | 1 |
| Tuncer, O | 1 |
| Miller, CS | 1 |
| Damm, DD | 1 |
| Tam, IM | 1 |
| Wandres, DL | 1 |
| Mehta, AV | 1 |
| Chidambaram, B | 1 |
| O'Riordan, AC | 1 |
| Zlotogorski, A | 1 |
| Seymour, RA | 1 |
| Pernu, HE | 1 |
| Oikarinen, K | 1 |
| Hietanen, J | 1 |
| Knuuttila, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Effects of PRF, CGF and AFG Application on Wound Healing Following Gingivectomy and Gingivoplasty Operations: a Randomized Controlled Clinical Trial[NCT04805463] | 19 participants (Actual) | Interventional | 2020-01-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for verapamil and Gingival Hyperplasia
| Article | Year |
|---|---|
Calcium-channel blockers and gingival hyperplasia.
Topics: Aged; Calcium Channel Blockers; Cardiovascular Diseases; Diltiazem; Female; Gingival Hyperplasia; Hu | 1992 |
Calcium channel blockers and gingival overgrowth.
Topics: Calcium Channel Blockers; Cyclosporins; Diltiazem; Fibroblasts; Gingival Hyperplasia; Humans; Nifedi | 1991 |
1 trial available for verapamil and Gingival Hyperplasia
| Article | Year |
|---|---|
Calcium antagonist-induced gingival hyperplasia.
Topics: Adult; Aged; Calcium Channel Blockers; Cross-Sectional Studies; Diltiazem; Gingival Hyperplasia; Hum | 1994 |
6 other studies available for verapamil and Gingival Hyperplasia
| Article | Year |
|---|---|
The effect of verapamil on the prevalence and severity of cyclosporine-induced gingival overgrowth in renal allograft recipients.
Topics: Adult; Antihypertensive Agents; Calcium Channel Blockers; Chi-Square Distribution; Cyclosporine; Dru | 1996 |
Gingival hyperplasia due to calcium antagonists.
Topics: Calcium Channel Blockers; Dihydropyridines; Diltiazem; Gingival Hyperplasia; Humans; Nifedipine; Ver | 1998 |
Incidence of verapamil-induced gingival hyperplasia in a dental population.
Topics: Age Factors; Dental Plaque Index; Gingival Hyperplasia; Humans; Incidence; Periodontal Index; Sex Fa | 1992 |
Verapamil-induced gingival hyperplasia in children.
Topics: Adolescent; Child; Female; Gingival Hyperplasia; Humans; Tachycardia, Supraventricular; Time Factors | 1992 |
Calcium blockers and gingival hyperplasia.
Topics: Calcium Channel Blockers; Dihydropyridines; Gingival Hyperplasia; Humans; Verapamil | 1991 |
Verapamil-induced gingival overgrowth: a clinical, histologic, and biochemic approach.
Topics: Adult; Female; Fibroblasts; Gingival Hyperplasia; Gingival Pocket; Humans; Recurrence; Verapamil | 1989 |